A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on: May 17,2024

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on:May 17,2024

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on: December 28,2023

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on:December 28,2023

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on: March 30,2024

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on:March 30,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on: February 24,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on:February 24,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c

Updated on: May 17,2024

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c

Updated on:May 17,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on: March 30,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on:March 30,2024

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on: March 30,2024

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on:March 30,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on: June 06,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on:June 06,2024

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on: March 08,2024

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on:March 08,2024

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on: March 08,2024

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on:March 08,2024

Radiation before mastectomy found to cut time delays for reconstructive surgery in breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast c

Updated on: April 06,2024

Radiation before mastectomy found to cut time delays for reconstructive surgery in breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast c

Updated on:April 06,2024